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INTRODUCTION
Crohn’s disease (CD) is a chronic relapsing inflammatory 
bowel disease characterized by transmural inflammation and 
may manifest with varying degrees of fibrosis resulting in 
intestinal narrowing or even obstruction. Irreversible bowel 
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Objective: To establish a novel standardized magnetization transfer ratio (MTR) parameter which considers the element of the 
normal bowel wall and to compare the efficacy of the MTR, normalized MTR, and standardized MTR in evaluating intestinal 
fibrosis in Crohn’s disease (CD). 
Materials and Methods: Abdominal magnetization transfer imaging from 20 consecutive CD patients were analyzed before 
performing elective operations. MTR parameters were calculated by delineating regions of interest in specified segments on MTR 
maps. Specimens with pathologically confirmed bowel fibrosis were classified into one of four severity grades. The correlation 
between MTR parameters and fibrosis score was tested by Spearman’s rank correlation. Differences in MTR, normalized MTR, 
and standardized MTR across diverse histologic fibrosis scores were analyzed using the independent sample t test or the Mann-
Whitney U test. The area under the receiver operating characteristic curve (AUC) was computed to test the efficacies of the 
MTR parameters in differentiating severe intestinal fibrosis from mild-to-moderate fibrosis.
Results: Normalized (r = 0.700; p < 0.001) and standardized MTR (r = 0.695; p < 0.001) showed a strong correlation with 
bowel fibrosis scores, followed by MTR (r = 0.590; p < 0.001). Significant differences in MTR (t = -4.470; p < 0.001), normalized 
MTR (Z = -5.003; p < 0.001), and standardized MTR (Z = -5.133; p < 0.001) were found between mild-to-moderate and severe 
bowel fibrosis. Standardized MTR (AUC = 0.895; p < 0.001) had the highest accuracy in differentiating severe bowel fibrosis 
from mild-to-moderate bowel wall fibrosis, followed by normalized MTR (AUC = 0.885; p < 0.001) and MTR (AUC = 0.798; p 
< 0.001).
Conclusion: Standardized MTR is slightly superior to MTR and normalized MTR and therefore may be an optimal parameter for 
evaluating the severity of intestinal fibrosis in CD.
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obstruction resulting from severely fibrotic bowel stricture 
commonly requires surgical excision (1). Therefore, an exact 
differentiation among various degrees of intestinal fibrosis 
and an accurate distinction of severely fibrotic bowel walls 
from mild-to-moderately fibrotic bowel walls is crucial and 
urgently needed for ensuring appropriate clinical treatment. 
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Recently, magnetization transfer (MT) magnetic 
resonance imaging (MRI), referred to as MT imaging (MTI), 
is a noninvasive method for accurately detecting and 
distinguishing varying degrees of intestinal fibrosis in CD 
(2-4). Bowel fibrosis in CD is characterized by excessive 
collagen accumulation in the extracellular matrix (5). As 
such, the concentration of macromolecules in the fibrotic 
intestinal walls, such as collagen, determines the image 
contrast of MTI (6). The concentration of macromolecules in 
the bowel walls can be quantitatively reflected indirectly by 
the MT ratio (MTR) (7, 8). The MTR increases with increasing 
bowel fibrosis in CD. A high MTR of the affected bowel wall, 
close to the muscle with the highest MTR in human tissue, 
indicates severe fibrosis (2). However, a low MTR may be 
detected in severely fibrotic bowel walls with a similarly low 
MTR of muscle in some cases due to individual differences. 
To facilitate the comparison between individual cases, the 
MTR of the affected bowel wall was divided by the MTR of 
the muscles on the same image to obtain a normalized MTR 
to minimize individual variation (3, 9). This normalized 
MTR also showed a high accuracy in detecting and further 
stratifying bowel fibrosis in CD (9). However, the approach 
using MTR or normalized MTR on the pathologic bowel wall 
to directly assess fibrosis does not take into account the 
already existing MTR of the normal intestine. It is noteworthy 
that the MTR of the normal bowel wall increases slightly due 
to the presence of intestinal smooth muscle (2, 7). However, 
it remains unclear whether or not including the MTR of the 
normal intestine could yield a new MTR parameter that may 
show greater accuracy in evaluating bowel fibrosis. A more 
accurate parameter for monitoring fibrosis progression will 
promote research on specific therapeutic strategies for bowel 
fibrosis. Therefore, the purpose of this study was to establish 
a new MTR parameter (standardized MTR) that includes the 
MTR of the normal intestine and to compare its efficacy with 
those of MTR and normalized MTR in assessing bowel fibrosis 
in patients with CD.
MATERIALS AND METHODS
Patients
The Institutional Ethics Review Board approved this 
prospective observational study, and patients with CD who 
underwent magnetic resonance enterography (MRE) provided 
written informed consent prior to study participation.
From July 2015 to April 2017, 22 consecutive CD patients 
who underwent MRE and surgical resection were recruited 
by the Inflammatory Bowel Disease Center. The inclusion 
criteria were as follows: 1) patients over 18 years of age 
with a preoperative diagnosis of strictured CD according 
to well-recognized clinical, endoscopic, imaging, and 
histological criteria; 2) underwent conventional MRE 
examination within 15 days before elective operation; and 3) 
had matching locations between histological examinations 
and MRE. The exclusion criteria were as follows: 1) 
insufficient MTI quality or 2) another concurrent intestinal 
disease.
MRI Protocol
As described in previous studies (10-12), patients 
took orally administered polyethylene glycol electrolyte 
dispersion after 6–8 hours of fasting to clean the intestinal 
tract. Then, 1600–2000 mL of 2.5% mannitol solution was 
given 1 hour before MRI to fill the small bowel. Next, 10 mg 
of raceanisodamine hydrochloride (Minsheng Pharmaceutical 
Group, Hangzhou, China) was injected intramuscularly 
into the buttock 10 minutes before scanning to inhibit 
gastrointestinal peristalsis. 
All MRE scans were performed using a 3T superconductive 
MR device (Magnetom Trio; Siemens Healthineers, Erlangen, 
Germany) equipped with multi-channel phased-array body 
coils and spinal surface coils. Axial breath-hold MTI was 
performed using two gradient-echo data sets with and 
without pre-saturation pulse (frequency offset: 1.2 kHz, 
duration: 9984 μs, effective flip angle: 500°, bandwidth: 
192 Hz, slice thickness: 4 mm). The conventional MRE 
sequences included axial and coronal breath-hold half-
Fourier acquisition single-shot turbo spin-echo T2-weighted 
(repetition time [TR]: 1200 ms; echo time [TE]: 87 ms; 
flip angle: 160°; matrix: 320 x 194; slice thickness: 4 mm) 
and coronal breath-hold fat-suppressed fast low angle 
shot T1-weighted (TR: 210 ms; TE: 2.18 ms; flip angle: 
70°; matrix: 320 x 200; slice thickness: 4 mm) images. 
After intravenous injection of 0.2 mL/kg gadopentetate 
dimeglumine (Beilu Pharmaceuticals, Beijing, China) 
at a rate of 2 mL/s, multiple coronal dynamic contrast-
enhanced, fat-suppressed, three-dimensional volumetric 
interpolated breath-hold examinations (TR: 4.37 ms; TE: 
1.37 ms; flip angle: 1°; matrix: 320 x 217; slice thickness: 
2 mm) were performed at 15, 40, 65, and 90 seconds from 
the beginning of the injection.
MRI Analysis




= (1 - Msat / M0) x 100%, where Msat and M0 indicate signal 
intensities acquired with and without off-resonance pre-
pulse saturation, respectively (2, 6, 7). MTR maps were 
produced using an in-house MATLAB script (MathWorks, 
Natick, MA, USA). The involved bowel segments were 
marked for region-by-region evaluation by a senior 
radiologist with 16 years of experience performing 
intestinal MRI and who was not blinded to the clinical, 
biochemical, and pathological data. Then, 3 MTR parameters 
were measured and calculated by a radiologist with 6 years 
of experience performing bowel MRI and who was blinded 
to the clinical, biochemical test, and pathological data. 
Three irregular regions of interest (ROIs) with different 
sizes were separately drawn on the pathologic bowel walls, 
normal bowel walls, and the psoas or gluteal muscle with 
a total of nine ROIs at the same slice. The normal bowel 
segment was defined as the bowel wall with a thickness of 
< 3 mm, with an isointensity on T2-weighted and contrast-
enhanced images, and without the presence of a lesion in 
a series of clinical data. Then, the average MTR of every 
tissue was calculated. The normalized MTR was calculated 
according to the following equation (3, 9): normalized MTR 
= MTRpathologic bowel wall / MTRmuscle. Considering the impact of 
a slight increase in the MTR of the normal bowel wall, we 
established a new MTR parameter according to the following 
equation and called this the standardized MTR: standardized 
MTR = (MTRpathologic bowel wall - MTRnormal bowel wall) / (MTRmuscle - 
MTRnormal bowel wall). This parameter was expected to eliminate 
the influence of background MTR of the normal bowel wall 
and to avoid overestimating the severity of bowel fibrosis. 
The mean areas of the ROIs in the affected bowel walls, 
normal bowel walls, and the psoas or gluteal muscle were 
97.52 ± 79.42 mm2, 38.51 ± 15.57 mm2, and 405.92 ± 
116.61 mm2, respectively.
Intestinal Segment Selection for Corresponding 
Histological Evaluation and MRI Assessment
Matched assessments between specimens and MRI were 
performed by a radiologist with 16 years of experience 
performing intestinal MRI and who was not blinded to the 
clinical, laboratory, imaging, and histopathological data. 
Matching locations between the resected bowel segments 
and MRI were identified using anatomic landmarks (surgically 
resected margins, ileocecal valve, or appendix) or gross 
lesions (bowel fistula or adhesion) (9, 13-15). A total of 2–4 
specimens were obtained from each patient according to 
the number of lesions and the extent of the disease. 
Histopathological Assessment
The whole specimen was embedded in paraffin after 
fixing in formalin and cut into slices 4-μm thick. All 
specimens were stained with Masson’s trichrome staining 
for histologic fibrosis scoring. The histologic slices from 
areas with the most severe fibrosis were graded from 0–3 
using a semi-quantitative scoring system by an experienced 
gastrointestinal pathologist with 10 years of experience in 
intestinal pathology and who was blinded to the clinical 
and imaging information (9, 16-18) (Table 1).
Statistical Analysis
Statistical analysis of the comparisons was performed 
using SPSS (version 20; IBM Corp., Armonk, NY, USA). A 
p value < 0.05 was considered statistically significant. 
Continuous variables were described as means ± standard 
deviation (normal distribution data) or medians and 
interquartile ranges (abnormal distribution data), and 
categorical variables were described as percentages and 
absolute values. The correlations between the three MTR 
parameters and fibrosis scores were tested by Spearman’s 
rank correlation. Differences in MTR, normalized MTR, and 
standardized MTR among diverse histologic fibrosis scores 
were tested using the independent sample t test or the 
Mann–Whitney U test according to the data type. The area 
under the receiver operating characteristic (ROC) curve 
(AUC) was utilized to test the efficiency of the three MTR 
parameters in differentiating severe intestinal fibrosis from 
mild-to-moderate intestinal fibrosis. 
Table 1. Histologic Scores for Assessing Severity of Fibrosis in Crohn’s Disease
Score Fibrosis
0 (none) No fibrosis
1 (mild) Minimal fibrosis in submucosa or subserosa
2 (moderate)
Increased submucosal fibrosis; septa extending into muscularis propria and/or septa extending through muscularis 
  propria; increase in subserosal collagen
3 (severe) Significant transmural scar; marked subserosal collagen
293
Three MTR Comparison for Assessment of Intestinal Fibrosis in CD
https://doi.org/10.3348/kjr.2019.0217kjronline.org
RESULTS
Demographic and Clinical Data
Twenty-two CD patients underwent MRE examination. 
Two patients, one with unsatisfactory MTI quality and one 
with a combined carcinoma of the intestine, were excluded. 
Ultimately, 20 patients (8 males, 12 females; average 
age: 30.5 ± 9.2 years) with 63 samples met the inclusion 
criteria and were recruited in this study. Statistically, the 
mean disease duration was 55.6 ± 45.8 months, and the 
mean interval between MRI and surgery was 6.4 ± 4.8 
days, with 12 patients with an interval shorter than 7 days 
and 8 patients with an interval between 7 and 15 days. 
Fourteen (70%) patients underwent ileocolectomy and six 
(30%) patients underwent partial small bowel resection. In 
addition, the CD activity parameter was 269.14 ± 100.40, 
the C-reactive protein level was 41.34 ± 17.44 mg/L, and 
the erythrocyte sedimentation rate was 36.60 ± 18.98 mm/h.
Histological Assessment
Of the 63 bowel specimens, 46 were from the most 
strictured segments in the jejunum (n = 5), proximal ileum 
(n = 10), and terminal ileum (n = 31), and 17 were from 
colonic lesions. Regarding the histological fibrosis of the 63 
specimens, 6 had mild, 35 had moderate, and 22 had severe 
fibrosis (Table 2). 
Comparison of the Efficacies among the Three MTR 
Parameters for Assessing Bowel Fibrosis
The normalized MTR (r = 0.700; p < 0.001) and 
standardized MTR (r = 0.695; p < 0.001) showed a strong 
correlation with bowel fibrosis scores, followed by MTR 
(r = 0.590; p < 0.001) (Fig. 1). Significant differences in 
MTR (t = -4.470; p < 0.001), normalized MTR (Z = -5.003; 
p < 0.001), and standardized MTR (Z = -5.133; p < 0.001) 
were found between mildly-to-moderately and severely 
(Fig. 2) fibrotic intestinal walls (Fig. 3, Table 3). Moreover, 
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Fig. 1. Correlation between three MTRs and histologic bowel fibrosis scores.  
Normalized MTR (r = 0.700; p < 0.001) (A) and standardized MTR (r = 0.695; p < 0.001) (B) were strongly correlated with bowel fibrosis scores, 
followed by MTR (r = 0.590; p < 0.001) (C). MTR = magnetization transfer ratio
A B C
Table 2. Demographic and Clinical Characteristics of Patients
n = 20
Sex (female/male) 12/8
Age, mean ± SD (years) 30.5 ± 9.2
Disease duration, mean ± SD (months) 55.6 ± 45.8
Interval between MRI and surgery, 
  mean ± SD (days)
6.4 ± 4.8
< 7 12
7–15  8 
Surgical type, n (%)
Ileocolectomy 14/20 (70)
Partial small bowel resection 6/20 (30)
Number of bowel specimens, n (%)
Jejunum 5/63 (7.9)
Proximal ileum 10/63 (15.9)
Terminal ileum 31/63 (49.2)
Colon 17/63 (27.0)




CDAI, mean ± SD 269.14 ± 100.40
CRP, mean ± SD (mg/L) 41.34 ± 17.44
ESR, mean ± SD (mm/h) 36.60 ± 18.98
CDAI = Crohn’s disease activity index, CRP = C-reactive protein, 
ESR = erythrocyte sedimentation rate, MRI = magnetic resonance 




between mild-to-moderate and severe bowel fibrosis (Fig. 3), 
demonstrating that standardized MTR was superior to MTR 
and normalized MTR.
The standardized MTR (AUC = 0.895; 95% confidence 
interval [CI], 0.807–0.982; p < 0.001) had the highest 
accuracy in differentiating severe bowel wall fibrosis 
from mild-to-moderate bowel wall fibrosis, followed by 
normalized MTR (AUC = 0.885; 95% CI, 0.803–0.966; p < 
0.001) and MTR (AUC = 0.798; 95% CI, 0.682–0.914; p < 
0.001) (Fig. 4). 
DISCUSSION
In this study, we found that the standardized MTR, which 
was strongly correlated with histologic bowel fibrosis scores 
and had the highest accuracy in differentiating severe 
Fig. 2. 36-year-old woman with severe Crohn’s disease in terminal ileum. 
A. Axial T2-weighted image and (B) axial contrast-enhanced T1-weighted image show marked bowel wall thickening and luminal stenosis with 
hyper-enhancement at terminal ileum (arrows). C-E. Axial MT imaging without (C) and with (D) MT pulse as well as pseudo-color MTR map 
(E) indicate that MT effect of terminal ileum (arrows; ROIs, 1–3; MTR, 44.2%; yellow-blue) is higher than that of normal small intestinal wall 
(hollow arrows; ROIs, 4–6; MTR, 26.0%; dark blue) and close to that of skeletal muscles (arrowheads; ROIs, 7–9; MTR, 52.0%; yellow). Averages 
of standardized MTR and normalized MTR of involved bowel wall are 0.70 and 0.85, respectively. F. Gross specimen from surgical excision 
demonstrates marked thickening of bowel wall with obvious luminal stenosis (arrows). G. Masson’s trichrome staining (magnification: x 20) 




















Three MTR Comparison for Assessment of Intestinal Fibrosis in CD
https://doi.org/10.3348/kjr.2019.0217kjronline.org
intestinal fibrosis from mild-to-moderate intestinal fibrosis, 
was an optimal parameter for evaluating the severity of 
intestinal fibrosis compared with MTR and normalized MTR.
MTI has been reported as a non-invasive method that 
can be effectively used for assessing intestinal fibrosis in 
CD patients (7). The quantitative parameters of MTI (MTR 
and normalized MTR) were both reported to be capable of 
characterizing the severity of bowel fibrosis in animal or 
human CD (2, 3, 7, 9). Our preliminary results and those 
of other studies showed that a higher MTR or normalized 
MTR of the thickened intestinal wall, similar to that of 
the muscle presenting the highest MTR in human tissue, 
indicated a higher fibrotic composition of the lesion (2, 
3, 9). However, in clinical practice, sometimes a relatively 
higher MTR or normalized MTR might be observed in the 
normal intestinal wall, which may hinder interpretations of 
the result. Other physiological macromolecules within the 
normal bowel wall, such as smooth muscle, would slightly 
increase the MTR or normalized MTR and would influence 
the accurate assessment of the severity of bowel fibrosis. 
This manifestation attracted our attention and provided 
the idea to include the already existing MTR of the normal 
intestine during the evaluation process when using MTI 
to quantitatively assess bowel fibrosis. Given that severe 
fibrotic bowel stricture leading to intestinal obstruction in 
CD patients invariably requires surgical excision and that 
non-severely fibrotic intestinal stricture may be relieved by 
medical treatment (1), it is of great importance for both 
radiologists and clinicians to select the most appropriate 
MTR parameter to evaluate the degree of intestinal 
fibrosis for guiding an individualized therapy. To minimize 



















































Fig. 3. Box plots showing differences of three MTRs between mild-to-moderate and severe bowel fibrosis. 
Significant differences in MTR (t = -4.470; p < 0.001) (A), normalized MTR (Z = -5.003; p < 0.001) (B), and standardized MTR (Z = -5.133; p < 
0.001) (C) were found between mild-to-moderate and severe bowel fibrosis.
A B C
Table 3. Comparison of MTR Parameters between Mild-to-






MTR (%) 34.730 ± 6.449 41.910 ± 5.313 < 0.001
Normalized MTR 0.734 (0.574–0.894)*   0.874 ± 0.062 < 0.001
Standardized MTR 0.469 (0.179–0.759)*   0.747 ± 0.142 < 0.001
*Normalized and standardized MTR with mild-to-moderate fibrosis 
of abnormal distribution were described as median (interquartile 




















Fig. 4. ROC curve analysis for differentiating severe bowel 
fibrosis from mild-to-moderate fibrosis. ROC curve analysis 
shows that standardized MTR is highly accurate with AUC of 0.895 
in distinguishing severe intestinal fibrosis from mild-to-moderate 
intestinal fibrosis, followed by normalized MTR (AUC = 0.885) and MTR 





diagnose bowel fibrosis, we developed a new parameter 
(standardized MTR) to quantify the severity of bowel 
fibrosis and to determine whether standardized MTR was 
superior to MTR or normalized MTR.
Our study indicated that standardized MTR, MTR, and 
normalized MTR were able to assess intestinal fibrosis in CD 
patients. The correlation strength of MTR and normalized 
MTR with bowel fibrosis in our study was similar to those 
reported previously (r = 0.74–0.77) (2, 9). As we expected, 
standardized MTR was one of the two parameters showing a 
strong correlation with histologic bowel fibrosis score in our 
study, and it showed the highest accuracy in differentiating 
severe intestinal fibrosis from mild-to-moderate intestinal 
fibrosis, when compared with normalized MTR and MTR. 
It was also noteworthy that there was no overlap in the 
interquartile ranges of standardized MTRs between mild-to-
moderate and severe bowel fibrosis, whereas the other two 
parameters had overlaps that should be considered when 
applying them in clinical practice. This result confirmed the 
ability of standardized MTR to accurately stratify the severity 
of bowel fibrosis. Moreover, standardized MTR helped to 
better minimize differences between individuals and was 
beneficial in comparing between patients with different 
severities or in the same patient before and after treatment. 
There are several limitations in our study. First, a relatively 
smaller sample of bowel segments with varying degrees of 
fibrosis were included in this study, and we did not include 
normal bowel segments, as only bowel segments with severe 
stricture were likely to be surgically resected. Second, it was 
difficult to accurately perform a point-by-point comparison 
of peristaltic bowels on MRI with the histopathologic 
specimens. Fortunately, by eliminating peristalsis of the 
bowel and shortening the time interval between the MRI 
examination and surgery, we believe that this problem was 
partially solved. Third, bias may have resulted from the 
absence of intra- or inter-observer variation in ROI selection 
as the distribution of varying degrees of intestinal fibrosis 
often shows inhomogeneity. However, we delineated three 
ROIs on the target bowel wall to reduce this bias.
In conclusion, standardized MTR was superior to MTR and 
normalized MTR and could be an optimal parameter for the 
quantitative assessment of the severity of bowel fibrosis in 
CD patients. 
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